Trial intelligence / Profile preview

Guchong granules for ovulatory dysfunctional uterine bleeding (phase II)

CTR20131988Phase 2Completed

Sponsor
Nanjing Dadong Pharmaceutical Technology
Start
Nov 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Guchong in dysfunctional uterine bleeding (DUB), sponsored by Nanjing Dadong Pharmaceutical Technology. Started Nov 2014; status: completed.

02

Drugs

Guchong
03

Conditions

dysfunctional uterine bleeding (DUB)

Beyond the preview

Go deeper on CTR20131988.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20131988.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call